Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

12,318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percent decrease of serum prostate-specific antigen after dutasteride administration is equivalent in men with clinical benign prostatic hyperplasia having baseline prostate-specific antigen >10 ng/mL and those having baseline prostate-specific antigen 2.5-10 ng/mL.
Takeshita H, Kawakami S, Yano A, Okada Y, Morozumi M, Yamada T. Takeshita H, et al. Among authors: yamada t. Int J Urol. 2017 Mar;24(3):238-239. doi: 10.1111/iju.13284. Epub 2017 Feb 16. Int J Urol. 2017. PMID: 28208224 No abstract available.
12,318 results
You have reached the last available page of results. Please see the User Guide for more information.